Pathway of oral absorption of heparin with sodium N-[8-(2-hydroxybenzoyl)amino]caprylate

被引:44
作者
Malkov, D [1 ]
Wang, HZ [1 ]
Dinh, S [1 ]
Gomez-Orellana, I [1 ]
机构
[1] Emisphere Technol Inc, Tarrytown, NY 10591 USA
关键词
heparin; oral drug delivery; caco-2; cells; transcellular absorption;
D O I
10.1023/A:1019802310702
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. The oral bioavailability of heparin is negligible. Recent studies, however, have shown that sodium N-[8-(2-hydroxybenzoyl) amino]caprylate (SNAC) and other N-acylated amino acids enable oral heparin absorption. To investigate the mechanism by which heparin crosses the intestinal epithelium in the presence of SNAC, we have used fluorescence microscopy to follow the transport of heparin across Caco-2 cell monolayers. Methods. The experiments were carried out on Caco-2 monolayers and Caco-2 cells grown to confluence on culture dishes, using different concentrations of SNAC. The localization of fluorescently labeled heparin was determined using epi-fluorescence and confocal microscopy. DNA dyes were used to determine the effect of SNAC on the plasma membrane integrity. F-actin was labeled with fluorescent phalloidin to investigate the stability of perijunctional actin rings in the presence of SNAC. Results. Heparin was detected in the cytoplasm only after incubation of the cells with heparin and SNAC. No DNA staining was observed in cells incubated with a DNA dye in the presence of SNAC concentrations at which heparin transport occurred. In addition, no signs of actin redistribution or perijunctional ring disbandment were observed during the transport of heparin. Conclusions. The results indicate that SNAC enables heparin transport across Caco-2 monolayers via the transcellular pathway. Heparin transport in the presence of SNAC is selective and does not involve permeabilization of the plasma membrane or tight junction disruption.
引用
收藏
页码:1180 / 1184
页数:5
相关论文
共 19 条
  • [1] Caco-2 monolayers in experimental and theoretical predictions of drug transport (Reprinted from Advanced Drug Delivery Reviews, vol 22, pg 67-84, 1996)
    Artursson, P
    Palm, K
    Luthman, K
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2001, 46 (1-3) : 27 - 43
  • [3] Oral delivery of anticoagulant doses of heparin - A randomized, double-blind, controlled study in humans
    Baughman, RA
    Kapoor, SC
    Agarwal, RK
    Kisicki, J
    Catella-Lawson, F
    FitzGerald, GA
    [J]. CIRCULATION, 1998, 98 (16) : 1610 - 1615
  • [4] Heparin absorption across the intestine:: Effects of sodium N-[8-(2-hydroxybenzoyl)amino]caprylate in rat in situ intestinal instillations and in Caco-2 monolayers
    Brayden, D
    Creed, E
    O'Connell, A
    Leipold, H
    Agarwal, R
    Leone-Bay, A
    [J]. PHARMACEUTICAL RESEARCH, 1997, 14 (12) : 1772 - 1779
  • [5] Regulation of the intestinal epithelial paracellular barrier
    Daugherty, AL
    Mrsny, RJ
    [J]. PHARMACEUTICAL SCIENCE & TECHNOLOGY TODAY, 1999, 2 (07): : 281 - 287
  • [6] Transcellular uptake mechanisms of the intestinal epithelial barrier - Part one
    Daugherty, AL
    Mrsny, RJ
    [J]. PHARMACEUTICAL SCIENCE & TECHNOLOGY TODAY, 1999, 2 (04): : 144 - 151
  • [7] Advances in the oral delivery of proteins
    Gomez-Orellana, I
    Paton, DR
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 1999, 9 (03) : 247 - 253
  • [8] Advances in the oral delivery of proteins
    Gomez-Orellana, I
    Paton, DR
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 1998, 8 (03) : 223 - 234
  • [9] JIANG LW, 1986, J CELL BIOL, V102, P853, DOI 10.1083/jcb.102.3.853
  • [10] LOW-MOLECULAR-WEIGHT HEPARIN FOR THE TREATMENT OF ACUTE ISCHEMIC STROKE
    KAY, R
    WONG, KS
    YU, YL
    CHAN, YW
    TSOI, TH
    AHUJA, AT
    CHAN, FL
    FONG, KY
    LAW, CB
    WONG, A
    WOO, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (24) : 1588 - 1593